Costs of adverse events associated with erlotinib or...

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla, Dolores, De Castro, Javier, Vidal, Oscar Juan, Grau, Santiago, Orofino, Javier, Gordo, Rocío, Rubio-Terrés, Carlos, Rubio-Rodríguez, Darío
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 9
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S121093
Date:
December, 2016
File:
PDF, 157 KB
english, 2016
Conversion to is in progress
Conversion to is failed